Cargando…
Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity
BACKGROUND: Both Leishmania braziliensis and Leishmania amazonensis induce cutaneous disease when injected in the skin of BALB/c mice. However, L. amazonensis may also visceralize in that strain of mice, infecting mainly the liver and spleen. In addition, whereas BALB/c mice die with a progressive c...
Autores principales: | Silva, Virgínia M. G., de-Araújo, Cíntia F., Navarro, Isabela C., Oliveira, Pablo R. S., Pontes–de-Carvalho, Lain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440558/ https://www.ncbi.nlm.nih.gov/pubmed/25971623 http://dx.doi.org/10.1186/s13104-015-1158-0 |
Ejemplares similares
-
Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally
por: de Araújo, Cintia F, et al.
Publicado: (2014) -
Mutilating localized cutaneous leishmaniasis caused by Leishmania guyanensis()
por: Silva, Dina Fabrício da, et al.
Publicado: (2023) -
Cutaneous Leishmaniasis Due to Leishmania aethiopica
por: van Henten, Saskia, et al.
Publicado: (2019) -
Development of Cutaneous Leishmaniasis after Leishmania Skin Test
por: Machado, Paulo R., et al.
Publicado: (2011) -
Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis()()
por: Sampaio, Raimunda Nonata Ribeiro, et al.
Publicado: (2021)